ZenaTech, Inc. (NASDAQ: ZENA) (FSE: 49Q) (BMV: ZENA), a technology solutions provider specializing in AI-powered drones, Drone as a Service (DaaS), enterprise software and quantum computing, announced that its ZenaDrone subsidiary has signed a memorandum of understanding (MOU) with Rattler Medical Inc. to develop and manufacture a drone-based battlefield blood delivery system. The proposed system will combine ZenaDrone's cargo drone capabilities with Rattler Medical's temperature-controlled blood transport containers to deliver blood to military medical personnel more quickly while reducing reliance on ground transportation in combat environments.
Under the agreement, the companies plan to develop and test a flying prototype within two to three months, evaluating delivery methods that include aerial release and landing-based deployment. ZenaDrone is targeting a demonstration at a U.S. military facility in summer 2027. The initiative expands ZenaTech's defense portfolio into battlefield medical logistics, with the companies seeking to improve blood resupply capabilities and reduce risks associated with transporting medical supplies through contested areas.
This development matters because timely access to blood can be life-saving for wounded soldiers, and traditional ground transport is often dangerous and slow in combat zones. By using drones to deliver blood, the system could significantly reduce the time between injury and transfusion, potentially improving survival rates. It also aligns with broader military efforts to leverage autonomous systems for logistics, keeping personnel out of harm's way.
ZenaTech, through its subsidiaries, focuses on AI autonomy drone platforms to transform commercial, government, and defense sectors. Its subsidiaries include drone manufacturing through ZenaDrone, a global Drone as a Service (DaaS) business, and an enterprise SaaS division of software brands. The company is executing an acquisition-led DaaS roll-up strategy to digitize and automate legacy service industries like land surveys and inspections, driving drone-based scalable, recurring revenue growth. With an operating footprint spanning North America, Europe, the Middle East, Asia, and Australia, ZenaTech is advancing AI drones for applications such as agriculture and logistics, as well as ISR, cargo, and counter-UAS for U.S. defense and NATO allies. The company is investing in next-generation technologies, including drone swarms, quantum computing, and advanced AI autonomy to capture long-term opportunities in key markets through its R&D initiatives.
For investors, the MOU signals ZenaTech's entry into a niche but critical defense medical logistics market. If successful, the technology could open new revenue streams and partnerships with military organizations. The news was reported by DefenseWireNews, a specialized communications platform focused on defense contractors and aerospace firms, which is part of the Dynamic Brand Portfolio at IBN. IBN provides InvestorWire for wire distribution and editorial syndication to 5,000+ outlets, among other services. The full press release can be viewed at https://ibn.fm/xSVke. More information about ZenaTech is available at https://www.zenatech.com/.
